Unlimited stock picks, top financial news, and more. ​

Company Overview and Recent Developments VistaGen Therapeutics (NASDAQ: VTGN) is a clinical-stage biotech focused on developing novel therapies for central nervous system (CNS) disorders (www.macrotrends.net).

Opening Recap Market Pulse: Stocks drifted in mixed fashion as traders parsed Beijing’s currency moves and a Tesla tech snafu that stole headlines. Key Movers:

Company Overview and Class Action Context Vistagen Therapeutics (Nasdaq: VTGN) is a clinical-stage biopharma focused on novel neuroactive nasal sprays for psychiatric disorders, notably social